Trusted by the world’s leading institutions
The latest clinical and basic research findings on thyroid disease will be presented at the American Thyroid Association's (ATA) 78th Annual Meeting, October 4-7, 2007, at the Sheraton New York Hotel and Towers in New York City.
Individuals with subclinical hypothyroidism"”a mildly underactive thyroid only detectable by a blood test"”are twice as likely to develop heart failure, compared to those with normal thyroid levels.
Children of women with hypothyroidism"”an under-active thyroid"”who had elevated thyroid stimulating hormone (TSH) in the first and second trimesters of pregnancy, had a significantly reduced ability to see visual contrasts, compared to women with hypothyroidism with normal TSH levels during the first two trimesters, and pregnant women with normal thyroid levels
Despite great concerns that small amounts of ingested perchlorate"”a chemical which is ever-present in the environment"”decreases thyroid function among individuals, it has no effect on the thyroid function of women in early pregnancy, including those with a low-iodine diet.
Patients with micropapillary thyroid cancer"”small tumors equal to or less than 1 centimer"”and tumors even smaller, less than 1 millimeter (mm)"”are more common and not without a risk as previously thought.
The ATA will be offering a translational symposium on the topic of iodine deficiency disorders (IDD), which will be presented at its upcoming 78th Annual Meeting in New York. The special symposium will address the current needs and challenges associated with this important health issue and will be held at the Sheraton New York Hotel and Towers on Sunday, October 7 from 10:30 a.m. to Noon.
"Cardiovascular and Metabolic Issues in Patients with Thyroid Dysfunction: Implications for treating Hypo- or Hyperthyroidism" will be the focus of a day-long scientific meeting on Friday, March 28 at the Marriott Metro Center in Washington, DC.
The American Thyroid Association (ATA) and ThyCa: Thyroid Cancer Survivors' Association, Inc. are awarding two new research grants in 2008 and renewing two grants on thyroid cancer, one of the few cancers significantly increasing in the number of newly-diagnosed patients.
Cancer recurrence is more common in patients with multifocal micropapillary cancer who are treated with less than near total thyroidectomy compared to patients with unifocal papillary cancer who are treated with less than near total thyroidectomy.
MicroRNA (miRNA) expression profiles can be used to identify an aggressive type of papillary thyroid cancer that is often otherwise difficult to detect.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right